Navigation Links
Consumer Group Welcomes Introduction of Stem Cell Agency Oversight Bill
Date:2/22/2008

SANTA MONICA, Calif., Feb. 22 /PRNewswire-USNewswire/ -- The Foundation for Taxpayer and Consumer Rights (FTCR) today welcomed the introduction of a bill in the California state Senate intended to reform the state stem cell agency.

The bill, SB 1565, was introduced by Sen. Sheila Kuehl (D-23) and Sen. George Runner (R-17) and seeks to ensure California's neediest residents will have access to therapies and drugs made possible by stem cell agency funding. The legislation also requires California's Little Hoover Commission to study the agency's conflict-ridden governance structure and report to the Legislature by July 1, 2009.

"The stem cell agency's oversight board was designed with built-in conflicts of interest and it's too big to be effective. They always have difficulties mustering a quorum," said John M. Simpson, FTCR's Stem Cell Project Director. "An outside analysis by unbiased observers can only be good. A hard-nosed look by the Little Hoover Commission is just what's needed."

FTCR said the provisions in the bill seeking to guarantee the state's neediest residents have affordable access to the results of state funded research are commendable steps in the right direction, but in fact do not go far enough to protect the interests of all California residents who are paying for the $6 billion stem cell program.

"We need a provision that allows the State Attorney General to intervene if drugs or therapies funded by the stem cell agency are priced unreasonably," said Simpson. "We've seen too many cases where companies benefit from publicly funded research and then set prices at obscene levels. They act like socialists when seeking research funding but are greedy capitalists when there are profits on the table."

FTCR said the leadership of the stem cell agency, the California Institute for Regenerative Medicine (CIRM), too frequently operates as if it were not a state agency. "SB 1565 is an important reminder that it is a public agency and that the Legislature should have a role in its oversight," said Simpson.

Proposition 71 that created CIRM provides that the act can be amended three years after the initiative was passed. Amendments require a super-majority of 70 percent. The initiative passed by 59 percent of Californians in 2004. FTCR's Stem Cell Oversight and Accountability Project is working to ensure that California's landmark stem cell research program offers accessible and affordable cures and treatments to the taxpayers who have funded it. The program will sell $3 billion in bonds over a decade to fund stem cell research. Financing charges mean the project, the largest source of stem cell research funding in the world, will cost California taxpayers $6 billion.

The Foundation for Taxpayer and Consumer Rights is California's leading non-profit and non-partisan consumer watchdog group. For more information visit us on the web at: http://www.ConsumerWatchdog.org.


'/>"/>
SOURCE Foundation for Taxpayer and Consumer Rights
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Consumers Offer to Pay More to Satisfy Health Demands
2. CIGNA Group Insurance Shows Consumers Theres More to Life Through a New Consumer Education Toolkit
3. Draxis Health selected by Johnson and Johnson Consumer Companies, Inc. for major contract manufacturing relationship
4. Naked Juice Brings Consumers Happiness by the Billions With First 100% Juice Smoothie Containing Probiotics
5. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
6. Hospitals Agree to Pay Fees in Exchange for More Income, but Consumers in the Dark About What Theyll be Charged Under Nunez Plan
7. PA Agriculture Department Warns Consumers of Tainted Raw Milk Sold by Perry County Dairy
8. Injuries, Deaths Tied to Consumer Drugs Rise Sharply
9. Highmark Blue Cross Blue Shield Introduces New Health Plan Comparison Tool for Consumers
10. Highmark Blue Shield Introduces New Health Plan Comparison Tool for Consumers
11. PA Department of Public Welfare Begins Outreach to Medical Assistance Consumers Following Burglary at State Office Building
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2017)... Texas (PRWEB) , ... August 19, 2017 , ... ... with contemporary illustrations of breastfeeding mothers. These illustrations show the diversity ... available in prints in a wide range of sizes. These illustrations are also ...
(Date:8/19/2017)... ... ... “Congratulations! It's A Boy! God’s Gift: A Story of Love”: a children’s book ... A Boy! God’s Gift: A Story of Love” is the creation of published authors, ... by Christian Faith Publishing, Dale Anthony and Rachael Anthony’s new book is a perfect ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... (“Quick”), a highly specialized asset-light logistics provider of complex transport solutions for ... agreement to purchase Unitrans International Corporation, a division of Roadrunner Transportation Systems, ...
(Date:8/18/2017)... ... August 18, 2017 , ... As an industry leader, ... webinar, they will present the line of epMotion automated liquid handling system. This ... can automate everyday pipetting tasks. , Ideal for scientists and lab technicians with ...
(Date:8/18/2017)... TX (PRWEB) , ... August 18, 2017 , ... ... assistance and financial planning services to communities in east Texas, is launching a ... Brain Tumor Foundation. , Founded in 1991, the Pediatric Brain Tumor Foundation (PBTF) ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... 2017  Axium Pharmaceuticals Inc., the creator of the drug Truveta ... beginning stages of an IPO. The United States ... average cost of a prescription epilepsy drug being $450.00-$1200.00 for a one ... AXIUM PHARMACEUTICALS, INC ... Another staggering figure is the fact that Americans spent $42 billion ...
(Date:8/14/2017)... and PETACH TIKVAH, Israel ... (NASDAQ: BCLI), a leading developer of adult stem cell ... second quarter ending June 30, 2017. ... of preparing for our pivotal Phase 3 trial to ... Lebovits , President and Chief Executive Officer of BrainStorm. ...
(Date:8/8/2017)... 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical ... financial results for the second quarter ended June 30, ... quarter 2017 and to date: ... for the Company,s lead project, BL-8040: ... BL-8040 as novel stem cell mobilization treatment for autologous ...
Breaking Medicine Technology: